STING1 and cystic fibrosis: Recently, evidence showed that the cGAS-STING pathway over-activation is involved in multiple inflammatory lung diseases including cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), asthma and COVID-19 [19,20].